青岛黄海制药有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
125
NMPA:125
Drug Approvals
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字H20254533
- Approval Date
- Jun 10, 2025
NMPA
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字H20254531
- Approval Date
- Jun 10, 2025
NMPA
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字H20254532
- Approval Date
- Jun 10, 2025
NMPA
Nifedipine Controlled-release Tablets
- Product Name
- 硝苯地平控释片
- Approval Number
- 国药准字H20249162
- Approval Date
- Oct 22, 2024
NMPA
Sildenafil Citrate Orodispersible Tablets
- Product Name
- 枸橼酸西地那非口崩片
- Approval Number
- 国药准字H20234296
- Approval Date
- Oct 18, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
Clinical Trials
No trials found
News
No news found